ProShare Advisors LLC

Position in OVID — Ovid Therapeutics Inc.

CIK 1357955 BETHESDA, MD

Position in OVID

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$53,931

+$49,952 QoQ

Shares Held

20,049

+57.2% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#89

of 130 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. OVID ranks #150 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	287,847	$142,982,240
2	REGN	Regeneron Pharmaceuticals, Inc.	119,240	$74,350,909
3	ALNY	Alnylam Pharmaceuticals, Inc.	128,514	$38,686,569
4	INCY	Incyte Corp	48,152	$5,458,510
5	MRNA	Moderna, Inc.	70,621	$4,945,588
6	CYTK	Cytokinetics Inc	27,121	$2,310,437
7	TECH	BIO-TECHNE Corp	30,597	$2,161,678
8	KRYS	Krystal Biotech, Inc.	4,760	$1,769,149

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$53,931	20,049	+57.2%	Shares	Sole	2026-08-11
2025-03-31	$3,979	12,754	-23.1%	Shares	Sole	2025-05-08
2024-12-31	$15,489	16,584	+8.2%	Shares	Sole	2025-02-14
2024-09-30	$18,078	15,321	+23.9%	Shares	Sole	2024-11-14
2024-06-30	$9,508	12,365	-21.1%	Shares	Sole	2024-08-13
2024-03-31	$47,781	15,666	+8.9%	Shares	Sole	2024-05-08
2023-12-31	$46,319	14,385	-0.9%	Shares	Sole	2024-02-14
2021-09-30	$48,756	14,511	+19.1%	Shares	Sole	2021-11-12
2021-06-30	$47,635	12,183	-43.3%	Shares	Sole	2021-08-13
2021-03-31	$86,385	21,489	+5.7%	Shares	Sole	2021-05-14
2020-12-31	$46,969	20,333	—	Shares	Sole	2021-02-09
No filing history on record for this holder in this stock.